Skip to main content
. 2011 May 29;5:27–35. doi: 10.4137/CCRPM.S6882

Table 2.

Maximum symptom score.

Symptom Whole group symptomatic
No acetazolamide symptomatic
Acetazolamide symptomatic
P
No. % No. % No. %
Shortness of breath with activity 213 87 125 89 84 91 0.61
Sleeping difficulty 182 74 109 78 69 75 0.61
Headache 162 66 99 71 61 66 0.48
Fatigue 160 65 94 67 64 70 0.70
Dizzy/lightheaded 113 46 68 49 43 47 0.78
General health limitation 99 41 53 38 44 48 0.13
Mental status changes 90 37 48 34 41 45 0.12
Shortness of breath at rest 77 31 43 31 32 35 0.52
Cough 74 30 34 24 37 41 0.008
GI upset 59 24 26 19 31 34 0.009
Peripheral edema 23 9 17 12 6 7 0.16
AMS by Lake Louise criteria 116 52 70 52 46 51 0.87